Back to resultsRapid Benzodiazepine Detoxification Using Flumazenil - 1
Primary Purpose
Substance-Related Disorders
Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Flumazenil
Sponsored by
About this trial
This is an interventional treatment trial for Substance-Related Disorders focused on measuring Substance-Related Disorders
Eligibility Criteria
Please contact site for information.
Sites / Locations
- Yale University, Psychiatry
Outcomes
Primary Outcome Measures
Benzodiazepine withdrawal severity
Secondary Outcome Measures
Full Information
NCT ID
NCT00000246
First Posted
September 20, 1999
Last Updated
September 6, 2016
Sponsor
Yale University
Collaborators
National Institute on Drug Abuse (NIDA)
1. Study Identification
Unique Protocol Identification Number
NCT00000246
Brief Title
Rapid Benzodiazepine Detoxification Using Flumazenil - 1
Official Title
Rapid Benzodiazepine Detoxification Using Flumazenil
Study Type
Interventional
2. Study Status
Record Verification Date
September 2016
Overall Recruitment Status
Completed
Study Start Date
January 1993 (undefined)
Primary Completion Date
December 1994 (Actual)
Study Completion Date
December 1994 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Yale University
Collaborators
National Institute on Drug Abuse (NIDA)
4. Oversight
5. Study Description
Brief Summary
The purpose of this study is to verify the hypothesis that the benzodiazepine antagonist, flumazenil, will reduce acute benzodiazepine withdrawal.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Substance-Related Disorders
Keywords
Substance-Related Disorders
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Enrollment
10 (Actual)
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
Flumazenil
Primary Outcome Measure Information:
Title
Benzodiazepine withdrawal severity
10. Eligibility
Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Please contact site for information.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Scott Woods, M.D.
Organizational Affiliation
Yale University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Yale University, Psychiatry
City
New Haven
State/Province
Connecticut
ZIP/Postal Code
06519
Country
United States
12. IPD Sharing Statement
Citations:
Citation
Woods, et al., Soc Neuroscience Abstracts 21: 2098, 1995.
Results Reference
background
Learn more about this trial
Rapid Benzodiazepine Detoxification Using Flumazenil - 1
We'll reach out to this number within 24 hrs